Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction

V. M. Corman, I. Eckerle, T. Bleicker, A. Zaki, O. Landt, M. Eschbach-Bludau, S. van Boheemen, R. Gopal, M. Ballhause, T. M. Bestebroer, D. Muth, M. A. Müller, J. F. Drexler, M. Zambon, A. D. Osterhaus, R. M. Fouchier, C. Drosten*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

448 Citations (Scopus)

Abstract

We present two real-time reverse-transcription polymerase chain reaction assays for a novel human coronavirus (CoV), targeting regions upstream of the E gene (upE) or within open reading frame (ORF)1b, respectively. Sensitivity for upE is 3.4 copies per reaction (95% confidence interval (CI): 2.5-6.9 copies) or 291 copies/mL of sample. No cross-reactivity was observed with coronaviruses OC43, NL63, 229E, SARS-CoV, nor with 92 clinical specimens containing common human respiratory viruses. We recommend using upE for screening and ORF1b for confirmation.

Original languageEnglish
JournalEurosurveillance
Volume17
Issue number39
DOIs
Publication statusPublished - Sept 2012

Fingerprint

Dive into the research topics of 'Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction'. Together they form a unique fingerprint.

Cite this